News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rho Release: Experienced Clinical Research Leader Joins Rho as Vice President, Operations



6/21/2011 1:43:54 PM

Chapel Hill, NC – – Amy Schaberg joined Rho on June 13, 2011 as Vice President, Operations. Ms. Schaberg brings more than 27 years of clinical research and drug development experience, including her most recent position at Inspire Pharmaceuticals as Vice President, Clinical Research. While at Inspire, she was responsible for the design and management of multiple clinical development programs involving three new chemical entities and seven INDs with an annual research budget of $20 million.

In her! new position with Rho, Ms. Schaberg will lead a growing team of more than 85 clinical research professionals. The addition of Ms. Schaberg represents a continued commitment by Rho to attract and retain the best and brightest employees in the field of clinical research and development. According to Laura Helms Reece, Chief Operating Officer at Rho, “We’re pleased to add Amy to our management team. Her depth of experience in clinical development adds to our already robust clinical operations team. We’re grateful that despite the economic downturn, Rho is continuing to hire for our clinical research programs.”

Rho is an actively growing company, having hired more than 32 new employees in the last six months. We are currently hiring and have open positions at all experience levels. To learn more about career ! opportunities at Rho, visit us at http://www.rhoworld.com/rho/career-center.

Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of services across the entire drug development process. For more than 25 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and governme! nt organizations. Our commitment to excellence, our innovative technol ogies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience.


Read at BioSpace.com


comments powered by Disqus
Rho
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES